These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4960848)

  • 1. [Research for resistance media to Cycloserine. II. The influences of the preservative method of media and the preservative period on the minimal inhibitory concentration of Cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1966 Jun; 20(6):573-8. PubMed ID: 4960848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D; Mysakowska H; Szarewicz-Adamczyk W; Litwin B
    Ann Univ Mariae Curie Sklodowska Med; 1967; 22():71-8. PubMed ID: 4308440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN; Gur'ian IE; Kochetov BI
    Probl Tuberk; 1972; 50(11):21-4. PubMed ID: 4630564
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on media for testing resitance to cycloserine. 4. Various lots of cycloserine and the minimal inhibitory concentration to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1967 May; 21(5):550-2. PubMed ID: 4965697
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of pH of media on the minimal inhibitory concentration of cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1965 Jun; 40(6):213-8. PubMed ID: 4955433
    [No Abstract]   [Full Text] [Related]  

  • 6. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

  • 7. Tubercle bacilli resistance to cycloserine.
    Zierski M; Rózewska M; Woźniak S
    Scand J Respir Dis Suppl; 1970; 71():291-5. PubMed ID: 4989519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Refractory tuberculosis: concept and clinical cases].
    Sunahara S
    Naika; 1971 Jun; 27(6):1358-63. PubMed ID: 4997127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Suitable pH region for resistance test of cycloserine and for the growth of Mycobacterium tuberculosis].
    Tamura M; Takano S
    Kekkaku; 1966 Nov; 41(11):517-23. PubMed ID: 4962768
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 11. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 12. Position of cycloserine in the treatment of pulmonary tuberculosis.
    Meyer A; Nadjar G
    Scand J Respir Dis Suppl; 1970; 71():139-43. PubMed ID: 5271974
    [No Abstract]   [Full Text] [Related]  

  • 13. On cycloserine in the treatment of pulmonary tuberculosis and its use for postoperative protection.
    Rivas Salazar JL
    Scand J Respir Dis Suppl; 1970; 71():314-24. PubMed ID: 5272002
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C
    Scand J Respir Dis Suppl; 1970; 71():296-305. PubMed ID: 5272000
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on drug resistance test medium of cycloserine. i. Comparison of the minimal intercepting concentrations of Mycobacterium tuberculosis on 1 percent Ogawa medium, Kirchner agar and Kirchner semi-solid agar medium].
    Tamura M; Igai S; Takano S
    Iryo; 1966 Jan; 20(1):71-5. PubMed ID: 4957725
    [No Abstract]   [Full Text] [Related]  

  • 16. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
    Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
    [No Abstract]   [Full Text] [Related]  

  • 17. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cycloserine in the treatment of pulmonary tuberculosis.
    Bumbacescu N
    Scand J Respir Dis Suppl; 1970; 71():115-9. PubMed ID: 5271970
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of cycloserine as an antituberculous drug.
    Gomi J
    Scand J Respir Dis Suppl; 1970; 71():130-2. PubMed ID: 5317742
    [No Abstract]   [Full Text] [Related]  

  • 20. Cycloserine and clinical phthisiology.
    Zapatero J; Garcia Moreno F; Torres G; Santamaria A; Ventura A
    Scand J Respir Dis Suppl; 1970; 71():252-5. PubMed ID: 5271996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.